Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · IEX Real-Time Price · USD
74.02
+3.10 (4.37%)
Apr 25, 2024, 4:00 PM EDT - Market closed
Dr. Reddy's Laboratories Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for RDY stock has a target of 80, which predicts an increase of 8.08% from the current stock price of 74.02.
Analyst Consensus: Buy
* Price targets were last updated on Jan 29, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for RDY is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $75 → $80 | Buy | Maintains | $75 → $80 | +8.08% | Jan 29, 2024 |
| Barclays | Barclays | Buy Maintains $67 → $70 | Buy | Maintains | $67 → $70 | -5.43% | Jun 1, 2023 |
| Barclays | Barclays | Buy Maintains $66 → $67 | Buy | Maintains | $66 → $67 | -9.48% | Oct 31, 2022 |
| Barclays | Barclays | Buy Maintains $69 → $66 | Buy | Maintains | $69 → $66 | -10.83% | Oct 25, 2022 |
| Barclays | Barclays | Buy Maintains $68 → $69 | Buy | Maintains | $68 → $69 | -6.78% | Sep 12, 2022 |
Financial Forecast
Revenue This Year
281.41B
from 245.88B
Increased by 14.45%
Revenue Next Year
300.41B
from 281.41B
Increased by 6.75%
EPS This Year
322.82
from 270.85
Increased by 19.19%
EPS Next Year
338.57
from 322.82
Increased by 4.88%
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 302.2B | 325.5B | 360.8B | 352.0B | 376.2B |
| Avg | 281.4B | 300.4B | 317.6B | 340.1B | 365.5B |
| Low | 235.5B | 249.6B | 266.7B | 325.1B | 351.1B |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 22.9% | 15.7% | 20.1% | 10.8% | 10.6% |
| Avg | 14.5% | 6.8% | 5.7% | 7.1% | 7.5% |
| Low | -4.2% | -11.3% | -11.2% | 2.4% | 3.2% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| High | 364.14 | 396.80 | 434.70 | 338.45 |
| Avg | 322.82 | 338.57 | 342.39 | 328.78 |
| Low | 180.81 | 217.95 | 250.88 | 315.89 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| High | 34.4% | 22.9% | 28.4% | -1.1% |
| Avg | 19.2% | 4.9% | 1.1% | -4.0% |
| Low | -33.2% | -32.5% | -25.9% | -7.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.